Endocrine Society Awarded NICHD Collaboration Award for PregSource

On November 2, the Endocrine Society was awarded the Collaboration Award on behalf of Diana Bianchi, MD, director of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) for its participation as a partner in PregSource, a crowdsourcing research project that aims to improve knowledge of pregnancy by collecting information directly from pregnant women.

PregSource allows women to track their pregnancies, and to share and compare their experiences with other users and healthcare providers. The goal of the project is to improve maternal care by providing a more complete picture of the pregnancy experience. The Endocrine Society’s role will be to disseminate PregSource messaging to members, health care providers, and patient networks (via the Hormone Health Network).

The award reflects the Society’s efforts to make women’s health a priority in research, patient care, and health policy. PregSource is expected to launch in January 2018.

The award was accepted by Endocrine Society president Lynnette Nieman, MD, Society CEO Barbara Byrd Keenan, FASAE, CAE, Society chief policy officer Mila Becker, and Society associate director, Science Policy, Joseph Laakso, PhD.

You may also like

  • Holly A. Ingraham, PhD, Receives FASEB Excellence in Science Lifetime Achievement Award

    Endocrine Society member Holly A. Ingraham, PhD, is the recipient of the FASEB Excellence in Science Lifetime Achievement Award. On April 8, the organization announced the winners of its 2024 Excellence in Science Awards, which highlight outstanding achievements by women in biological sciences who demonstrate not only excellence and innovation in their research fields, but…

  • Endocrine Society Celebrates Special Diabetes Program Extension

    The Endocrine Society applauds Congress for approving the first funding increase for the Special Diabetes Program in two decades. The U.S. Senate voted Friday March 8 to extend the program, which supports both diabetes care and research into type 1 diabetes, until the end of 2024. This is part of the six-bill package funding several…

Find more in